Evidence map›Paper›PMID 41915743›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Spirocyclic β-lactone secondary metabolites modulate spliceosome function.

Kathryn E Penton, Sydney A Bates, Hannah L Thirman, Crissey D Cameron, Christopher Jurich, Madeline J Grider-Hayes, Ming Jiang, Michael R Savona, Zhongyue J Yang, Lars Plate and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kathryn E PentonDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0001-8417-4849
Sydney A BatesDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.ORCID 0009-0005-8952-6766
Hannah L ThirmanVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0002-3735-9995
Crissey D CameronDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.
Christopher JurichDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.
Madeline J Grider-HayesDepartment of Pediatrics-Neurology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045.ORCID 0000-0003-3684-9885
Ming JiangDepartment of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.ORCID 0000-0002-1927-5667
Michael R SavonaDepartment of Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.ORCID 0000-0003-3763-5504
Zhongyue J YangDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0003-0395-6617
Lars PlateDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0003-4363-6116
Jonathan M IrishVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0001-9428-8866
Brian O BachmannDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232.ORCID 0000-0001-5815-1176

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Single Cell Methods for Bioeffector Discovery and AnalysisR01CA226833 · NCI · VANDERBILT UNIVERSITY · PI BRIAN O BACHMANN, Jonathan Michael Irish · 2019 to 2026
$6.1M
Vanderbilt Chemical Biology Interface Training ProgramT32GM149371 · NIGMS · VANDERBILT UNIVERSITY · PI Lars Plate · 2023 to 2026
$1.7M
HHS | National Institutes of Health (NIH) R01CA226833HHS | National Institutes of Health (NIH) T32GM149371HHS | National Institutes of Health (NIH) U01TR002526NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA226833NIGMS NIH HHS T32 GM065086NIGMS NIH HHS T32 GM149371
6 · The paper itself

Abstract

Spirocyclic β-lactones (SβLs) are ring-strain activated natural products produced by actinomycetota, possessing potent and selective cytotoxicity, and with an unknown pharmacological mechanism. To further the understanding of their mechanism of action and the discovery of new SβLs, we obtained a series of known and previously not isolated SβLs from

Indexed as

LactonesSpiro CompoundsSpliceosomesStreptomycesHumansMetabolomicsMultigene FamilySecondary MetabolismStructure-Activity RelationshipLactonesSpiro Compoundsalternative splicingfunctional metabolomicsnatural product discoveryspliceosomethermal proteome profiling

Identifiers

PMID41915743
PMCPMC13056070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.